Coccidiosis is a
parasitic disease, which is caused due to microscopic coccidian
protozoa that mainly infect animal species. The coccidian infection
is characterized by incursion of the intestinal wall of the animals
that damages mucosal and sub-mucosal tissue of the intestine. This
disease is prevalent in most of the animal species such as swine,
cattle, poultry and companion animals while it is more prevalent in
poultry. The coccidian infection can be prevented and treated with
anti-coccidiosis drugs such as ionophore anticoccidials, antibiotic
anticoccidials, and chemical derivative anticoccidials.
Increasing
incidences of coccidian diseases among poultry and companion animals
have resulted in loss of millions of dollars for the treatment of
coccidiosis. This factor is the major driver that compels the growth
of the coccidiosis treatment market globally. Moreover, this market
is also driven by several other factors such as rising global
population and per capita consumption of meat, increasing adoption of
intensive farming methods, and rising demand for meat proteins which
has further increased meat production especially in developed
countries. In addition, increasing government spending on poultry in
several countries of the world would impose a positive impact on the
growth of this market. However, growth of the market can be
restrained by factors such as food safety concerns and increasing
meat prices globally, which hinders the consumption of meat.
The coccidiosis
treatment market can be segmented based on the type of drugs,
infected animal species, and geography. On the basis of drugs
utilized for the treatment of coccidiosis, global market can be
segmented into ionophore drugs, antibiotic drugs, and chemical
derivative drugs. Antibiotic drugs are expected to be the key product
for coccidiosis treatment due to the increased demand and usage of
antibiotics and rising awareness about the benefits associated with
these drugs.
Based on infected
animal forms the global market can be segmented into swine, poultry,
companion animals, fish, and cattle. Poultry segment is expected to
be the major contributor towards global market revenues due to
increased demand for meat and rising awareness about various
treatment options of coccidiosis that would further result in
increased production of meat.
Download Report
Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=13823
Geographically, the
coccidiosis treatment market can be segmented into five major regions
such as North America, Europe, Asia Pacific, Latin America and Middle
East & Africa. Factors such as rising awareness about poultry and
companion health in emerging economies, and increased investment
opportunities in anti-coccidiosis pharmaceutical production would
drive growth of this market in most of the regions of the world.
North America was
observed to be the largest coccidiosis treatment market especially
due to huge demand for meat food and associated products and rising
number of poultry and companion animals in the region. The U.S. was
the major contributor towards North America coccidiosis treatment
market revenues in 2015. The U.S. is characterized by a myriad of big
players having their presence in antimicrobial pharmaceutical
production as well as meat production. Europe was observed to be the
second largest market in coccidiosis treatment market owing to
increased demand for ionophore anticoccidials and antibiotic
anticoccidials from countries such as Germany, U.K., and France.
However, in upcoming
years Asia Pacific and Latin America are expected to increase their
share in the global market with increased adoption of coccidiosis
treatment drugs. In addition, the emerging countries such as India,
Brazil, Mexico and China are expected to increase their market share
at a rapid pace during the forecast period. Coccidiosis treatment
market in Middle East and Africa is not well established; hence, it
contributes a very small share towards the global market.
Pre-Book Full
Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=13823<ype=S
Some of the key
players operating in this market include Bayer Animal Health,
Boehringer Ingelheim Vetmedica, Inc., Ceva Santé Animale, Elanco (an
Eli Lilly company), Intas Pharmaceuticals Ltd., Jurox Pty Ltd., Merck
Animal Health, Merial (a Sanofi company), Vétoquinol S.A., Virbac
S.A., and Zoetis, Inc. among others.
About Us
Transparency Market
Research (TMR) is a market intelligence company, providing global
business information reports and services. Our exclusive blend of
quantitative forecasting and trends analysis provides forward-looking
insight for thousands of decision makers. TMR’s experienced team of
analysts, researchers, and consultants, use proprietary data sources
and various tools and techniques to gather, and analyze information.
Our business offerings represent the latest and the most reliable
information indispensable for businesses to sustain a competitive
edge.
Each TMR syndicated
research report covers a different sector - such as pharmaceuticals,
chemicals, energy, food & beverages, semiconductors, med-devices,
consumer goods and technology. These reports provide in-depth
analysis and deep segmentation to possible micro levels. With wider
scope and stratified research methodology, TMR’s syndicated reports
strive to provide clients to serve their overall research
requirement.
US Office
Contact
90 State Street,
Suite 700
Albany, NY 12207
Tel:
+1-518-618-1030
USA - Canada Toll
Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment